Gengenbach, L.; Graziani, G.; Reinhardt, H.; Rösner, A.; Braun, M.; Möller, M.-D.; Greil, C.; Wäsch, R.; Engelhardt, M.
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. Cancers 2021, 13, 4320.
https://doi.org/10.3390/cancers13174320
AMA Style
Gengenbach L, Graziani G, Reinhardt H, Rösner A, Braun M, Möller M-D, Greil C, Wäsch R, Engelhardt M.
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. Cancers. 2021; 13(17):4320.
https://doi.org/10.3390/cancers13174320
Chicago/Turabian Style
Gengenbach, Laura, Giulia Graziani, Heike Reinhardt, Amelie Rösner, Magdalena Braun, Mandy-Deborah Möller, Christine Greil, Ralph Wäsch, and Monika Engelhardt.
2021. "Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors" Cancers 13, no. 17: 4320.
https://doi.org/10.3390/cancers13174320
APA Style
Gengenbach, L., Graziani, G., Reinhardt, H., Rösner, A., Braun, M., Möller, M.-D., Greil, C., Wäsch, R., & Engelhardt, M.
(2021). Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. Cancers, 13(17), 4320.
https://doi.org/10.3390/cancers13174320
